Another pharma collaboration for the advancement of cancer therapies ... Mar 22
AIM ImmunoTech Inc. announced today that the post-COVID-19 “Long Hauler†portion of the active AMP-511 Expanded Access Program (EAP) protocol received approval ... Dec 26
The New $75 Million Fund will Provide Grants and Loans to New York City-Based Social Services and Cultural Organizations to Support Them in the ... Mar 21
-Advertisements-